Authors:
Thurnher, D
Kletzmayr, J
Formanek, M
Quint, C
Czerny, C
Burian, M
Kornek, G
Citation: D. Thurnher et al., Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx, ONCOL-BASEL, 61(2), 2001, pp. 143-146
Authors:
Kwasny, W
Kornek, G
Haider, K
Valencak, J
Ulrich-Pur, H
Penz, M
Lang, F
Depisch, D
Scheithauer, W
Citation: W. Kwasny et al., Treatment of advanced, refractory breast cancer with alternating docetaxeland epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor, BREAST CANC, 63(3), 2000, pp. 235-241
Authors:
Raderer, M
Valencak, J
Osterreicher, C
Drach, J
Hejna, M
Kornek, G
Scheithauer, W
Brodowicz, T
Chott, A
Dragosics, B
Citation: M. Raderer et al., Chemotherapy for the treatment of patients with primary high grade gastricB-cell lymphoma of modified Ann Arbor Stages IE and IIE, CANCER, 88(9), 2000, pp. 1979-1985
Authors:
Raderer, M
Vorbeck, F
Formanek, M
Osterreicher, C
Valencak, J
Penz, M
Kornek, G
Hamilton, G
Dragosics, B
Chott, A
Citation: M. Raderer et al., Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma, BR J CANC, 83(4), 2000, pp. 454-457
Authors:
Kornek, G
Reiner, A
Sagaster, P
Stierer, M
Mayer, A
Ludwig, H
Citation: G. Kornek et al., Effect of interferon alpha-2a on hormone receptor status in patients with advanced breast cancer, CANCER INV, 17(3), 1999, pp. 189-194